肺がん治療薬の世界市場（～2026年）

• 英文タイトル：Global Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12552
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、薬物、手術、放射線療法）市場規模、用途別（早期・中期肺がん治療、進行性肺がん治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別肺がん治療薬の競争状況、市場シェア
・世界の肺がん治療薬市場：種類別市場規模 2015年-2020年（化学療法、標的療法、薬物、手術、放射線療法）
・世界の肺がん治療薬市場：種類別市場規模予測 2021年-2026年（化学療法、標的療法、薬物、手術、放射線療法）
・世界の肺がん治療薬市場：用途別市場規模 2015年-2020年（早期・中期肺がん治療、進行性肺がん治療）
・世界の肺がん治療薬市場：用途別市場規模予測 2021年-2026年（早期・中期肺がん治療、進行性肺がん治療）
・北米の肺がん治療薬市場分析：米国、カナダ
・ヨーロッパの肺がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肺がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肺がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肺がん治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Roche、Merck、AstraZeneca、Sanofi-Aventis、Eli Lilly and Company、Abbott、Akebia Therapeutics、Agennix AG
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Lung Cancer Therapeutics Market
The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026.

Global Lung Cancer Therapeutics Scope and Market Size
Lung Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Roche
Merck
AstraZeneca
Sanofi-Aventis
Eli Lilly and Company
Abbott
Akebia Therapeutics
Agennix AG

Market segment by Type, the product can be split into
Chemotherapy
Targeted therapy
Drugs
Surgery
Radiotherapy
Market segment by Application, split into
Treatment Of Early And Middle Lung Cancer
Treatment Of Advanced Lung Cancer

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Targeted therapy
1.4.4 Drugs
1.4.5 Surgery
1.4.6 Radiotherapy
1.5 Market by Application
1.5.1 Global Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Treatment Of Early And Middle Lung Cancer
1.5.3 Treatment Of Advanced Lung Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Therapeutics Market Perspective (2015-2026)
2.2 Global Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Lung Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapeutics Players by Market Size
3.1.1 Global Top Lung Cancer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Therapeutics Market Concentration Ratio
3.2.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2019
3.3 Lung Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Lung Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Lung Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Lung Cancer Therapeutics Market Size (2015-2020)
6.2 Lung Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Lung Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Lung Cancer Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Lung Cancer Therapeutics Market Size (2015-2020)
7.2 Lung Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Lung Cancer Therapeutics Market Size (2015-2020)
8.2 Lung Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Lung Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Lung Cancer Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Lung Cancer Therapeutics Market Size (2015-2020)
9.2 Lung Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Lung Cancer Therapeutics Market Size (2015-2020)
10.2 Lung Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Lung Cancer Therapeutics Market Size (2015-2020)
11.2 Lung Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Lung Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Lung Cancer Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Lung Cancer Therapeutics Market Size (2015-2020)
12.2 Lung Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Lung Cancer Therapeutics Introduction
13.1.4 Pfizer Revenue in Lung Cancer Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Lung Cancer Therapeutics Introduction
13.2.4 Roche Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Lung Cancer Therapeutics Introduction
13.3.4 Merck Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.3.5 Merck Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Lung Cancer Therapeutics Introduction
13.4.4 AstraZeneca Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Sanofi-Aventis
13.5.1 Sanofi-Aventis Company Details
13.5.2 Sanofi-Aventis Business Overview
13.5.3 Sanofi-Aventis Lung Cancer Therapeutics Introduction
13.5.4 Sanofi-Aventis Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.5.5 Sanofi-Aventis Recent Development
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Details
13.6.2 Eli Lilly and Company Business Overview
13.6.3 Eli Lilly and Company Lung Cancer Therapeutics Introduction
13.6.4 Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.6.5 Eli Lilly and Company Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Lung Cancer Therapeutics Introduction
13.7.4 Abbott Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.7.5 Abbott Recent Development
13.8 Akebia Therapeutics
13.8.1 Akebia Therapeutics Company Details
13.8.2 Akebia Therapeutics Business Overview
13.8.3 Akebia Therapeutics Lung Cancer Therapeutics Introduction
13.8.4 Akebia Therapeutics Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.8.5 Akebia Therapeutics Recent Development
13.9 Agennix AG
13.9.1 Agennix AG Company Details
13.9.2 Agennix AG Business Overview
13.9.3 Agennix AG Lung Cancer Therapeutics Introduction
13.9.4 Agennix AG Revenue in Lung Cancer Therapeutics Business (2015-2020)
13.9.5 Agennix AG Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Lung Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Lung Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted therapy
Table 7. Key Players of Drugs
Table 8. Key Players of Surgery
Table 9. Key Players of Radiotherapy
Table 10. Global Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Lung Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Lung Cancer Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Lung Cancer Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Lung Cancer Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Lung Cancer Therapeutics Players
Table 21. Global Lung Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Lung Cancer Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapeutics as of 2019)
Table 24. Global Lung Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Lung Cancer Therapeutics Product Solution and Service
Table 27. Date of Enter into Lung Cancer Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Lung Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Lung Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Lung Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Lung Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 37. North America Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 39. North America Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 43. Europe Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 49. China Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 51. China Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 55. Japan Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 67. India Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 69. India Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Lung Cancer Therapeutics Market Share (2019-2020)
Table 73. Central & South America Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Sanofi-Aventis Company Details
Table 98. Sanofi-Aventis Business Overview
Table 99. Sanofi-Aventis Product
Table 100. Sanofi-Aventis Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 101. Sanofi-Aventis Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Product
Table 105. Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 106. Eli Lilly and Company Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Product
Table 110. Abbott Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 111. Abbott Recent Development
Table 112. Akebia Therapeutics Business Overview
Table 113. Akebia Therapeutics Product
Table 114. Akebia Therapeutics Company Details
Table 115. Akebia Therapeutics Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 116. Akebia Therapeutics Recent Development
Table 117. Agennix AG Company Details
Table 118. Agennix AG Business Overview
Table 119. Agennix AG Product
Table 120. Agennix AG Revenue in Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 121. Agennix AG Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted therapy Features
Figure 4. Drugs Features
Figure 5. Surgery Features
Figure 6. Radiotherapy Features
Figure 7. Global Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Treatment Of Early And Middle Lung Cancer Case Studies
Figure 9. Treatment Of Advanced Lung Cancer Case Studies
Figure 10. Lung Cancer Therapeutics Report Years Considered
Figure 11. Global Lung Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Lung Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Lung Cancer Therapeutics Market Share by Players in 2019
Figure 16. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2019
Figure 18. North America Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

非小細胞肺がん治療薬の世界市場（～2026年）

Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04010 2020年11月20日 97Pages
当調査資料は非小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（Alimta、Iressa、Avastin、Tarceva、Zykadia、Tagrisso、Xalkori、Cyramza、Opdivo、Alecensa）市場規模、用途別（病院、クリニック）市場規模、地域...

肺がん診断・治療の世界市場（～2026年）

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12547 2020年11月25日 128Pages
当調査資料は肺がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（非小細胞肺がん、小細胞肺がん）市場規模、用途別（病院、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

小細胞肺がん治療薬の世界市場（～2026年）

Global Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04651 2020年11月20日 133Pages
当調査資料は小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

肺癌の世界市場（～2026年）

Global Lung Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY12551 2020年11月25日 92Pages
当調査資料は肺癌のグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線療法、光線力学療法、レーザー療法）市場規模、用途別（病院・クリニック、がん研究センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

肺がんリキッドバイオプシーの世界市場（～2026年）

Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026
MRC2-11QY12550 2020年11月25日 91Pages
当調査資料は肺がんリキッドバイオプシーのグローバル市場について調査・分析したレポートです。種類別（CTC、CtDNA、エクソソーム・RNA、その他）市場規模、用途別（クリニック、病院、診療所研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

小細胞肺がん治療の世界市場（～2026年）

Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04652 2020年11月20日 99Pages
当調査資料は小細胞肺がん治療のグローバル市場について調査・分析したレポートです。種類別（小細胞がん、混合型小細胞がん）市場規模、用途別（手術、放射線療法、化学療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

肺がん診断の世界市場（～2026年）

Global Lung Cancer Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY12549 2020年11月25日 90Pages
当調査資料は肺がん診断のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他）市場規模、用途別（産業、医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

肺がん診断検査の世界市場（～2026年）

Global Lung Cancer Diagnostic Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY12548 2020年11月25日 94Pages
当調査資料は肺がん診断検査のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法）市場規模、用途別（精密医療、個別化医療、がんモニタリング）市場規模、地域別（北米、米...

mRNA癌ワクチン・治療薬の世界市場（～2026年）

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY03858 2020年11月20日 92Pages
当調査資料はmRNA癌ワクチン・治療薬のグローバル市場について調査・分析したレポートです。種類別（腺癌、粘液性癌、腺扁平上皮癌）市場規模、用途別（感染症、がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

膵臓がん治療薬の世界市場（～2026年）

Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04150 2020年11月20日 91Pages
当調査資料は膵臓がん治療薬のグローバル市場について調査・分析したレポートです。種類別（生物学、化学療法、標的療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
非小細胞肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non-small Cell Lung Cancer Therapeu…
肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
小細胞肺がん治療薬の世界市場（～2026年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…